What is the current annual EBITDA of AZN?

As of today, AZN annual EBITDA is $19.38B

What is 1-year change in AZN annual EBITDA?

AZN annual EBITDA is up +8.51% year-over-year

What is 3-year change in AZN annual EBITDA?

AZN annual EBITDA is up +87.92% over the past 3 years

How far is AZN annual EBITDA from its all-time high?

AZN annual EBITDA is currently at its all-time high

How does AZN annual EBITDA rank versus sector peers?

AZN annual EBITDA is higher than 99.38% of companies in Healthcare sector

When is AZN next annual earnings release?

The next annual earnings release for AZN is on February 9, 2027

What is the current quarterly EBITDA of AZN?

As of today, AZN quarterly EBITDA is $6.04B

What is AZN quarterly EBITDA most recent change?

AZN quarterly EBITDA was up +16.99% on September 30, 2026

What is 1-year change in AZN quarterly EBITDA?

AZN quarterly EBITDA is up +18.66% year-over-year

How far is AZN quarterly EBITDA from its all-time high?

AZN quarterly EBITDA is currently at its all-time high

How does AZN quarterly EBITDA rank versus sector peers?

AZN quarterly EBITDA is higher than 99.32% of companies in Healthcare sector

When is AZN next earnings release?

The next earnings release for AZN is on February 9, 2027

What is the current TTM EBITDA of AZN?

As of today, AZN TTM EBITDA is $21.12B

What is AZN TTM EBITDA most recent change?

AZN TTM EBITDA was up +4.71% on September 30, 2026

What is 1-year change in AZN TTM EBITDA?

AZN TTM EBITDA is up +9.68% year-over-year

How far is AZN TTM EBITDA from its all-time high?

AZN TTM EBITDA is currently at its all-time high

How does AZN TTM EBITDA rank versus sector peers?

AZN TTM EBITDA is higher than 99.32% of companies in Healthcare sector

When is AZN next earnings release?

The next earnings release for AZN is on February 9, 2027

AstraZeneca PLC (AZN) EBITDA History & Chart Since 1990

Annual EBITDA

$19.38B$1.52B+8.51%

December 31, 2025

Summary

Current Value: As of today, AZN annual EBITDA is $19.38B, up +8.51% on December 31, 2025
Historical Performance: AZN annual EBITDA is up +87.92% over the past 3 years, up +155.67% over the past 5 years
All-Time High Comparison: AZN annual EBITDA is currently at its all-time high
3-Year Low Comparison: AZN annual EBITDA is +87.92% above its 3-year low of $10.31B reached on an earlier date
Sector Comparison: AZN annual EBITDA is higher than 99.38% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

AZN Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$19.38B	+8.5%	+87.9%	+155.7%	+33.4%
Quarterly EBITDA	Sep 30, 26	$6.04B	+18.7%	+83.6%	+124.7%	+86.4%
TTM EBITDA	Sep 30, 26	$21.12B	+9.7%	+63.8%	+124.2%	+37.7%
Price	Nov 12, 26	$184.38	+110.3%	+191.9%	+213.6%	+692.0%
PE Ratio	Nov 12, 26	34.54	+18.6%	+3.4%	-62.8%	+450.9%
Annual Revenue	Dec 31, 25	$58.88B	+8.8%	+32.8%	+113.4%	+76.7%
Annual EPS	Dec 31, 25	$3.28	+45.7%	+211.3%	+169.6%	+17.6%
Annual EBIT	Dec 31, 25	$13.64B	+6.6%	+169.5%	+191.1%	+7.8%
Annual Net Income	Dec 31, 25	$10.26B	+45.6%	+211.5%	+226.2%	+26.8%

EBITDA Highs

AZN Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$19.38B	Dec 31, 25	at high
5Y	$19.38B	Dec 31, 25	at high
All	$19.38B	Dec 31, 25	at high

EBITDA Lows

AZN Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$10.31B	N/A	+87.9%
5Y	$6.97B	Dec 31, 21	+178.2%
All	$1.17B	Dec 31, 93	+1552.9%

EBITDA History

Year	Value	Change
2025	$19.38B	+8.5%
2024	$17.86B	+24.5%
2023	$14.35B	+39.1%
2022	$10.31B	+48.1%
2021	$6.97B	-8.1%
2020	$7.58B	+35.6%
2019	$5.59B	+21.1%
2018	$4.62B	-22.1%
2017	$5.92B	+0.9%
2016	$5.87B	-6.0%
2015	$6.25B	-8.9%
2014	$6.86B	-22.0%
2013	$8.80B	-21.7%
2012	$11.23B	-20.5%
2011	$14.13B	-2.8%
2010	$14.54B	+11.3%
2009	$13.06B	+10.0%
2008	$11.87B	+19.2%

Year	Value	Change
2007	$9.96B	+10.2%
2006	$9.04B	+18.3%
2005	$7.64B	+36.3%
2004	$5.60B	+7.7%
2003	$5.20B	+2.5%
2002	$5.07B	+8.9%
2001	$4.66B	+0.7%
2000	$4.63B	+60.2%
1999	$2.89B	+36.9%
1998	$2.11B	+5.6%
1997	$2.00B	+10.5%
1996	$1.81B	+16.7%
1995	$1.55B	+12.4%
1994	$1.38B	+17.6%
1993	$1.17B	-3.7%
1992	$1.22B	-12.8%
1991	$1.40B	+11.2%
1990	$1.26B	-

FAQ

What is the current annual EBITDA of AZN?: As of today, AZN annual EBITDA is $19.38B
What is 1-year change in AZN annual EBITDA?: AZN annual EBITDA is up +8.51% year-over-year
What is 3-year change in AZN annual EBITDA?: AZN annual EBITDA is up +87.92% over the past 3 years
How far is AZN annual EBITDA from its all-time high?: AZN annual EBITDA is currently at its all-time high
How does AZN annual EBITDA rank versus sector peers?: AZN annual EBITDA is higher than 99.38% of companies in Healthcare sector
When is AZN next annual earnings release?: The next annual earnings release for AZN is on February 9, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Quarterly EBITDA

$6.04B$877.00M+16.99%

September 30, 2026

Summary

Current Value: As of today, AZN quarterly EBITDA is $6.04B, up +16.99% on September 30, 2026
Historical Performance: AZN quarterly EBITDA is up +18.66% year-over-year, up +83.59% over the past 3 years
All-Time High Comparison: AZN quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: AZN quarterly EBITDA is +131.24% above its 3-year low of $2.61B reached on December 31, 2023
Sector Comparison: AZN quarterly EBITDA is higher than 99.32% of companies in Healthcare sector

Performance

AZN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$6.04B	+17.0%	+18.7%	+83.6%	+124.7%
Annual EBITDA	Dec 31, 25	$19.38B	–	+8.5%	+87.9%	+155.7%
TTM EBITDA	Sep 30, 26	$21.12B	+4.7%	+9.7%	+63.8%	+124.2%
Price	Nov 12, 26	$184.38	+16.3%	+110.3%	+191.9%	+213.6%
PE Ratio	Nov 12, 26	34.54	-9.7%	+18.6%	+3.4%	-62.8%
Quarterly Revenue	Sep 30, 26	$16.21B	+5.4%	+7.4%	+41.0%	+64.3%
Quarterly EPS	Sep 30, 26	$2.00	+24.2%	+148.1%	+354.1%	+462.3%
Quarterly EBIT	Sep 30, 26	$4.44B	+37.1%	+24.9%	+120.9%	+4535.0%
Quarterly Net Income	Sep 30, 26	$3.12B	+24.3%	+23.7%	+126.2%	+288.8%

Quarterly EBITDA Highs

AZN Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$6.04B	Sep 30, 26	at high
3Y	$6.04B	Sep 30, 26	at high
5Y	$6.04B	Sep 30, 26	at high
All	$6.04B	Sep 30, 26	at high

Quarterly EBITDA Lows

AZN Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$4.44B	Dec 31, 25	+36.1%
3Y	$2.61B	Dec 31, 23	+131.2%
5Y	$2.02B	Jun 30, 22	+199.3%
All	-$4.83B	Dec 31, 98	+225.0%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$6.04B	+17.0%
Jun 2026	$5.16B	-5.7%
Mar 2026	$5.47B	+23.3%
Dec 2025	$4.44B	-12.8%
Sep 2025	$5.09B	+4.7%
Jun 2025	$4.86B	-2.1%
Mar 2025	$4.97B	+14.6%
Dec 2024	$4.33B	-5.9%
Sep 2024	$4.60B	+11.8%
Jun 2024	$4.12B	-8.5%
Mar 2024	$4.50B	+72.3%
Dec 2023	$2.61B	-20.6%
Sep 2023	$3.29B	+7.1%
Jun 2023	$3.07B	-20.0%
Mar 2023	$3.84B	+42.6%
Dec 2022	$2.69B	+2.2%
Sep 2022	$2.63B	+30.5%
Jun 2022	$2.02B	-6.7%
Mar 2022	$2.16B	-16.6%
Dec 2021	$2.60B	-3.5%
Sep 2021	$2.69B	+47.5%
Jun 2021	$1.82B	-31.2%
Mar 2021	$2.65B	+17.0%
Dec 2020	$2.26B	+19.0%
Sep 2020	$1.90B	-3.3%
Jun 2020	$1.97B	-1.1%
Mar 2020	$1.99B	-5.9%
Dec 2019	$2.11B	+40.1%
Sep 2019	$1.51B	+22.4%
Jun 2019	$1.23B	-31.6%
Mar 2019	$1.80B	-39.9%
Dec 2018	$2.99B	+89.6%
Sep 2018	$1.58B	+8.2%
Jun 2018	$1.46B	+40.6%
Mar 2018	$1.04B	-6.1%
Dec 2017	$1.11B	-39.0%
Sep 2017	$1.81B	+61.4%
Jun 2017	$1.12B	-28.8%
Mar 2017	$1.58B	-34.3%
Dec 2016	$2.40B	+33.0%
Sep 2016	$1.80B	+120.0%
Jun 2016	$819.24M	-51.5%
Mar 2016	$1.69B	-0.9%
Dec 2015	$1.71B	+13.5%
Sep 2015	$1.50B	-10.3%
Jun 2015	$1.68B	+3.5%
Mar 2015	$1.62B	+105.9%
Dec 2014	$786.01M	-52.6%
Sep 2014	$1.66B	-16.9%
Jun 2014	$1.99B	+4.0%
Mar 2014	$1.92B	-55.1%
Dec 2013	$4.27B	+101.1%
Sep 2013	$2.12B	-4.4%
Jun 2013	$2.22B	+4.4%
Mar 2013	$2.13B	-27.4%
Dec 2012	$2.93B	+6.1%
Sep 2012	$2.76B	+15.3%
Jun 2012	$2.40B	-9.2%
Mar 2012	$2.64B	-5.5%
Dec 2011	$2.79B	-13.8%
Sep 2011	$3.24B	-6.1%
Jun 2011	$3.45B	-11.6%
Mar 2011	$3.90B	-17.8%
Dec 2010	$4.75B	+68.9%
Sep 2010	$2.81B	-15.8%
Jun 2010	$3.34B	-10.4%
Mar 2010	$3.72B	+3.9%
Dec 2009	$3.58B	-1.6%

Month	Value	Change
Sep 2009	$3.64B	+16.5%
Jun 2009	$3.12B	-6.7%
Mar 2009	$3.35B	+58.4%
Dec 2008	$2.12B	-27.4%
Sep 2008	$2.92B	+5.7%
Jun 2008	$2.76B	-3.5%
Mar 2008	$2.86B	+29.0%
Dec 2007	$2.22B	-8.8%
Sep 2007	$2.43B	+6.4%
Jun 2007	$2.28B	-8.1%
Mar 2007	$2.48B	+7.6%
Dec 2006	$2.31B	-0.1%
Sep 2006	$2.31B	+4.4%
Jun 2006	$2.21B	+1.9%
Mar 2006	$2.17B	+10.9%
Dec 2005	$1.96B	+3.7%
Sep 2005	$1.89B	-5.1%
Jun 2005	$1.99B	+13.5%
Mar 2005	$1.76B	+8.9%
Dec 2004	$1.61B	+11.6%
Sep 2004	$1.44B	+12.3%
Jun 2004	$1.29B	-9.3%
Mar 2004	$1.42B	+3.4%
Dec 2003	$1.37B	-9.5%
Sep 2003	$1.52B	+6.5%
Jun 2003	$1.42B	-10.6%
Mar 2003	$1.59B	+20.9%
Dec 2002	$1.32B	+9.2%
Sep 2002	$1.20B	+160.2%
Jun 2002	$462.98M	-69.6%
Mar 2002	$1.52B	+20.5%
Dec 2001	$1.27B	+12.6%
Sep 2001	$1.12B	-2.5%
Jun 2001	$1.15B	-11.5%
Mar 2001	$1.30B	+0.9%
Dec 2000	$1.29B	+8.7%
Sep 2000	$1.19B	-4.3%
Jun 2000	$1.24B	+3.9%
Mar 2000	$1.19B	+50.7%
Dec 1999	$792.00M	-32.2%
Sep 1999	$1.17B	-7.9%
Jun 1999	$1.27B	-71.9%
Mar 1999	$4.52B	+193.6%
Dec 1998	-$4.83B	-307.3%
Sep 1998	$2.33B	+168.1%
Jun 1998	$869.00M	-64.1%
Mar 1998	$2.42B	+154.8%
Dec 1997	-$4.41B	-310.1%
Sep 1997	$2.10B	-8.1%
Jun 1997	$2.28B	0.0%
Mar 1997	$2.28B	+180.2%
Dec 1996	-$2.85B	-223.1%
Sep 1996	$2.31B	+1.5%
Jun 1996	$2.28B	0.0%
Mar 1996	$2.28B	+147.9%
Dec 1995	-$4.75B	-345.6%
Sep 1995	$1.94B	+411.0%
Jun 1995	$378.70M	-81.2%
Mar 1995	$2.02B	+150.1%
Dec 1994	-$4.03B	-329.9%
Sep 1994	$1.75B	-4.6%
Jun 1994	$1.84B	0.0%
Mar 1994	$1.84B	+147.2%
Dec 1993	-$3.90B	-353.4%
Sep 1993	$1.54B	-12.1%
Jun 1993	$1.75B	0.0%
Mar 1993	$1.75B	-

FAQ

What is the current quarterly EBITDA of AZN?: As of today, AZN quarterly EBITDA is $6.04B
What is AZN quarterly EBITDA most recent change?: AZN quarterly EBITDA was up +16.99% on September 30, 2026
What is 1-year change in AZN quarterly EBITDA?: AZN quarterly EBITDA is up +18.66% year-over-year
How far is AZN quarterly EBITDA from its all-time high?: AZN quarterly EBITDA is currently at its all-time high
How does AZN quarterly EBITDA rank versus sector peers?: AZN quarterly EBITDA is higher than 99.32% of companies in Healthcare sector
When is AZN next earnings release?: The next earnings release for AZN is on February 9, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

TTM EBITDA

$21.12B$949.98M+4.71%

September 30, 2026

Summary

Current Value: As of today, AZN TTM EBITDA is $21.12B, up +4.71% on September 30, 2026
Historical Performance: AZN TTM EBITDA is up +9.68% year-over-year, up +63.81% over the past 3 years
All-Time High Comparison: AZN TTM EBITDA is currently at its all-time high
3-Year Low Comparison: AZN TTM EBITDA is +64.82% above its 3-year low of $12.81B reached on December 31, 2023
Sector Comparison: AZN TTM EBITDA is higher than 99.32% of companies in Healthcare sector

Performance

AZN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$21.12B	+4.7%	+9.7%	+63.8%	+124.2%
Annual EBITDA	Dec 31, 25	$19.38B	–	+8.5%	+87.9%	+155.7%
Quarterly EBITDA	Sep 30, 26	$6.04B	+17.0%	+18.7%	+83.6%	+124.7%
Price	Nov 12, 26	$184.38	+16.3%	+110.3%	+191.9%	+213.6%
PE Ratio	Nov 12, 26	34.54	-9.7%	+18.6%	+3.4%	-62.8%
TTM Revenue	Sep 30, 26	$62.34B	+1.8%	+7.3%	+38.5%	+81.2%
TTM EPS	Sep 30, 26	$5.34	+28.8%	+77.3%	+182.3%	+742.5%
TTM EBIT	Sep 30, 26	$14.71B	+6.4%	+15.8%	+100.1%	+243.3%
TTM Net Income	Sep 30, 26	$11.03B	+5.7%	+17.2%	+86.8%	+652.1%

TTM EBITDA Highs

AZN TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$21.12B	Sep 30, 26	at high
3Y	$21.12B	Sep 30, 26	at high
5Y	$21.12B	Sep 30, 26	at high
All	$21.12B	Sep 30, 26	at high

TTM EBITDA Lows

AZN TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$19.25B	N/A	+9.7%
3Y	$12.81B	Dec 31, 23	+64.8%
5Y	$9.27B	Mar 31, 22	+127.8%
All	-$421.81M	Dec 31, 95	+5105.9%

TTM EBITDA History

Month	Value	Change
Sep 2026	$21.12B	+4.7%
Jun 2026	$20.17B	+1.5%
Mar 2026	$19.87B	+2.6%
Dec 2025	$19.36B	+0.6%
Sep 2025	$19.25B	+2.6%
Jun 2025	$18.76B	+4.1%
Mar 2025	$18.02B	+2.7%
Dec 2024	$17.55B	+10.9%
Sep 2024	$15.83B	+9.0%
Jun 2024	$14.52B	+7.8%
Mar 2024	$13.47B	+5.2%
Dec 2023	$12.81B	-0.6%
Sep 2023	$12.89B	+5.4%
Jun 2023	$12.23B	+9.4%
Mar 2023	$11.18B	+17.6%
Dec 2022	$9.51B	+1.0%
Sep 2022	$9.41B	-0.6%
Jun 2022	$9.47B	+2.1%
Mar 2022	$9.27B	-5.0%
Dec 2021	$9.75B	+3.5%
Sep 2021	$9.42B	+9.1%
Jun 2021	$8.63B	-1.6%
Mar 2021	$8.78B	+8.1%
Dec 2020	$8.12B	+1.9%
Sep 2020	$7.96B	+5.2%
Jun 2020	$7.57B	+10.8%
Mar 2020	$6.83B	+2.8%
Dec 2019	$6.64B	-11.7%
Sep 2019	$7.53B	-1.0%
Jun 2019	$7.60B	-2.9%
Mar 2019	$7.83B	+10.8%
Dec 2018	$7.07B	+36.5%
Sep 2018	$5.18B	-4.3%
Jun 2018	$5.41B	+6.6%
Mar 2018	$5.08B	-9.6%
Dec 2017	$5.61B	-18.7%
Sep 2017	$6.91B	+0.1%
Jun 2017	$6.90B	+4.6%
Mar 2017	$6.59B	-1.7%
Dec 2016	$6.71B	+11.5%
Sep 2016	$6.02B	+5.3%
Jun 2016	$5.72B	-13.0%
Mar 2016	$6.57B	+1.1%
Dec 2015	$6.50B	+16.5%
Sep 2015	$5.58B	-2.7%
Jun 2015	$5.74B	-5.3%
Mar 2015	$6.05B	-4.7%
Dec 2014	$6.35B	-35.4%
Sep 2014	$9.83B	-4.5%
Jun 2014	$10.30B	-2.2%
Mar 2014	$10.53B	-2.0%
Dec 2013	$10.74B	+14.2%
Sep 2013	$9.40B	-6.4%
Jun 2013	$10.04B	-1.7%
Mar 2013	$10.21B	-4.8%
Dec 2012	$10.73B	+1.3%
Sep 2012	$10.59B	-4.3%
Jun 2012	$11.07B	-8.7%
Mar 2012	$12.12B	-9.4%
Dec 2011	$13.38B	-12.7%
Sep 2011	$15.34B	+2.9%
Jun 2011	$14.91B	+0.8%
Mar 2011	$14.80B	+1.2%
Dec 2010	$14.62B	+8.7%
Sep 2010	$13.45B	-5.8%
Jun 2010	$14.28B	+1.5%
Mar 2010	$14.07B	+2.7%
Dec 2009	$13.69B	+12.0%

Month	Value	Change
Sep 2009	$12.23B	+6.3%
Jun 2009	$11.51B	+3.3%
Mar 2009	$11.14B	+4.6%
Dec 2008	$10.65B	-0.9%
Sep 2008	$10.75B	+4.7%
Jun 2008	$10.26B	+4.9%
Mar 2008	$9.79B	+4.0%
Dec 2007	$9.41B	-1.0%
Sep 2007	$9.50B	+1.3%
Jun 2007	$9.39B	+0.7%
Mar 2007	$9.32B	+3.5%
Dec 2006	$9.01B	+4.0%
Sep 2006	$8.66B	+5.1%
Jun 2006	$8.24B	+2.8%
Mar 2006	$8.01B	+5.5%
Dec 2005	$7.60B	+4.8%
Sep 2005	$7.25B	+6.6%
Jun 2005	$6.80B	+11.6%
Mar 2005	$6.09B	+5.9%
Dec 2004	$5.76B	+4.4%
Sep 2004	$5.52B	-1.3%
Jun 2004	$5.59B	-2.4%
Mar 2004	$5.73B	-2.9%
Dec 2003	$5.90B	+0.9%
Sep 2003	$5.85B	+5.6%
Jun 2003	$5.54B	+21.0%
Mar 2003	$4.58B	+1.5%
Dec 2002	$4.51B	+1.1%
Sep 2002	$4.46B	+1.9%
Jun 2002	$4.38B	-13.6%
Mar 2002	$5.07B	+4.6%
Dec 2001	$4.84B	-0.5%
Sep 2001	$4.87B	-1.3%
Jun 2001	$4.93B	-1.7%
Mar 2001	$5.02B	+2.2%
Dec 2000	$4.91B	+11.3%
Sep 2000	$4.41B	+0.4%
Jun 2000	$4.39B	-0.7%
Mar 2000	$4.42B	-42.9%
Dec 1999	$7.75B	+264.3%
Sep 1999	$2.13B	-35.3%
Jun 1999	$3.29B	+13.8%
Mar 1999	$2.89B	+268.0%
Dec 1998	$785.10M	-34.9%
Sep 1998	$1.21B	+23.7%
Jun 1998	$975.55M	-59.2%
Mar 1998	$2.39B	+5.9%
Dec 1997	$2.26B	-40.9%
Sep 1997	$3.82B	-5.3%
Jun 1997	$4.03B	+0.1%
Mar 1997	$4.03B	+0.1%
Dec 1996	$4.02B	+89.9%
Sep 1996	$2.12B	+21.8%
Jun 1996	$1.74B	+1,184.3%
Mar 1996	-$160.41M	+62.0%
Dec 1995	-$421.81M	-240.2%
Sep 1995	$300.94M	+153.4%
Jun 1995	$118.74M	-92.5%
Mar 1995	$1.58B	+12.9%
Dec 1994	$1.40B	-8.8%
Sep 1994	$1.53B	+16.4%
Jun 1994	$1.32B	+7.2%
Mar 1994	$1.23B	+7.8%
Dec 1993	$1.14B	-77.4%
Sep 1993	$5.03B	+44.0%
Jun 1993	$3.50B	+100.0%
Mar 1993	$1.75B	-

FAQ

What is the current TTM EBITDA of AZN?: As of today, AZN TTM EBITDA is $21.12B
What is AZN TTM EBITDA most recent change?: AZN TTM EBITDA was up +4.71% on September 30, 2026
What is 1-year change in AZN TTM EBITDA?: AZN TTM EBITDA is up +9.68% year-over-year
How far is AZN TTM EBITDA from its all-time high?: AZN TTM EBITDA is currently at its all-time high
How does AZN TTM EBITDA rank versus sector peers?: AZN TTM EBITDA is higher than 99.32% of companies in Healthcare sector
When is AZN next earnings release?: The next earnings release for AZN is on February 9, 2027

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + D&A

Data Sources & References

AZN Official Website www.astrazeneca.com
AZN Profile on Yahoo Finance finance.yahoo.com/quote/AZN
AZN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/azn